Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System

Author(s): Zsófia Majláth, József Toldi, Ferenc Fülöp, László Vécsei

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 9 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Parkinson’s disease is a common progressive neurodegenerative disorder presenting with characteristic motor symptoms. Non-motor dysfunctions and therapyrelated complications frequently develop, but are often underdiagnosed and undertreated. Levodopa- induced dyskinesia and impulse control disorders are suggested to share pathophysiological processes and m a y be related to alterations of the glutamatergic neurotransmission. Anti- glutamatergic interventions are therefore worth considering: several lines of evidence already indicate their beneficial effect. The kynurenine pathway offers the endogenous glutamate receptor antagonist kynurenic acid, which may act as a promising candidate for future drug development with the aim of assessment of the motor symptoms and therapy-related complications of Parkinson’s disease.

Keywords: Parkinson’s disease, kynurenic acid, neuroprotection, NMDA receptor, glutamate, levodopa-induced dyskinesia, excitotoxicity.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 28 March, 2016
Page: [874 - 883]
Pages: 10
DOI: 10.2174/0929867323666160212121915
Price: $65

Article Metrics

PDF: 35
PRC: 1